Q2 2024 · 13F-HR
HARBOURVEST PARTNERS LLCholdings as filed
Filed 2024-08-14 · accession 0000950123-24-008364
$187.9M
Reported value
40
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 888787108 | TOST | Toast, Inc. | $58.8M | 31.3% | 2,282,878 | Common | SOLE |
| 94419L101 | W | Wayfair Inc. | $56.0M | 29.8% | 1,062,126 | Common | SOLE |
| 418100103 | HCP2EUR | HashiCorp, Inc. | $22.6M | 12.1% | 671,908 | Common | SOLE |
| 35969L108 | YMM | Full Truck Alliance Co. Ltd. | $7.7M | 4.10% | 957,580 | Common | SOLE |
| 68217N105 | — | Omega Therapeutics, Inc. | $7.3M | 3.87% | 3,512,110 | Common | SOLE |
| 52603A208 | LC | LendingClub Corp. | $4.3M | 2.31% | 513,440 | Common | SOLE |
| 74340E103 | PGNY | Progyny, Inc. | $2.6M | 1.37% | 89,654 | Common | SOLE |
| 428050108 | HSAI | Hesai Group | $2.5M | 1.35% | 606,061 | Common | SOLE |
| 45256X103 | IBRX | ImmunityBio, Inc. | $2.1M | 1.13% | 335,709 | Common | SOLE |
| 093712107 | BE | Bloom Energy Corporation | $2.0M | 1.06% | 162,199 | Common | SOLE |
| 00091G104 | ACVA | ACV Auctions, Inc. | $2.0M | 1.05% | 108,058 | Common | SOLE |
| 75943R102 | RLAY | Relay Therapeutics, Inc. | $1.9M | 1.03% | 296,402 | Common | SOLE |
| 45332Y109 | NARIUSD | Inari Medical | $1.9M | 0.99% | 38,540 | Common | SOLE |
| 98983V106 | ZUOUSD | Zuora, Inc. | $1.6M | 0.87% | 163,894 | Common | SOLE |
| 25402D102 | DOCN | DigitalOcean, Inc. | $1.5M | 0.82% | 44,210 | Common | SOLE |
| 68134L109 | OLOGBX | Olo, Inc. | $1.5M | 0.80% | 341,837 | Common | SOLE |
| 26622P107 | DOCS | Doximity, Inc. | $1.4M | 0.74% | 49,804 | Common | SOLE |
| 438333106 | HNST | Honest Company Inc. | $1.4M | 0.74% | 475,629 | Common | SOLE |
| 03213A104 | AMPL | Amplitude Inc. | $1.4M | 0.72% | 153,018 | Common | SOLE |
| 83542D300 | SONDQ | Sonder Holdings, Inc. | $1.0M | 0.55% | 225,112 | Common | SOLE |
| 320551104 | DIBS | 1stdibs.com, Inc. | $895,737 | 0.48% | 199,496 | Common | SOLE |
| 45828L108 | IAS | Integral Ad Science, Inc. | $892,092 | 0.47% | 91,779 | Common | SOLE |
| 22266M104 | COUR | Coursera, Inc. | $759,762 | 0.40% | 106,112 | Common | SOLE |
| 00827B106 | AFRM | Affirm, Inc. | $701,174 | 0.37% | 23,210 | Common | SOLE |
| 91332U101 | U | Unity Software | $555,994 | 0.30% | 34,194 | Common | SOLE |
| 729139105 | PLRX | Pliant Therapeutics, Inc. | $531,416 | 0.28% | 49,434 | Common | SOLE |
| 29975E109 | EB4 | Eventbrite, Inc. | $494,474 | 0.26% | 102,164 | Common | SOLE |
| 98980F104 | GTM | ZoomInfo Technologies Inc | $494,110 | 0.26% | 38,693 | Common | SOLE |
| 10920V404 | — | NeueHealth, Inc. | $286,797 | 0.15% | 52,720 | Common | SOLE |
| 74767V109 | QS | QuantumScape Corporation | $277,975 | 0.15% | 56,499 | Common | SOLE |
| 683712103 | OPEN | Opendoor Technologies Inc. | $85,941 | 0.05% | 46,707 | Common | SOLE |
| 15673T100 | IPSC | Century Therapeutics, Inc. | $73,996 | 0.04% | 29,018 | Common | SOLE |
| 760273102 | RPTX | Repare Therapeutics, Inc. | $40,511 | 0.02% | 12,276 | Common | SOLE |
| 81750R102 | MCRB1EUR | Seres Therapeutics, Inc. | $35,729 | 0.02% | 49,363 | Common | SOLE |
| 69404D108 | PACB | Pacific Biosciences of California, Inc. | $32,173 | 0.02% | 23,484 | Common | SOLE |
| 75120L100 | — | Rallybio Holdings, LLC | $29,315 | 0.02% | 21,877 | Common | SOLE |
| 69353Y103 | PMVP | PMV Pharmaceuticals | $18,683 | 0.01% | 11,533 | Common | SOLE |
| 65343E108 | NXTCEUR | NextCure, Inc. | $15,970 | 0.01% | 10,044 | Common | SOLE |
| 01626L105 | — | Aligos Therapeutics, Inc. | $6,574 | 0.00% | 18,783 | Common | SOLE |
| 04634X202 | — | Astra Space, Inc. | $6,263 | 0.00% | 12,444 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.